Breast Epithelial Stem Cell Culture Medium for Organoid Formation

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current methods are unable to support the long-term culture of breast epithelial stem cells or the formation of breast organoids that closely resemble breast tumours.

Innovation Solution

A culture medium comprising an ErbB3/4 ligand, one or more FGFR2b ligands, and a Wnt agonist is used to expand breast epithelial stem cells, allowing for the formation of breast organoids.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional culture media are used, then other epithelial stem cells can be maintained, but breast epithelial stem cells cannot be cultured long-term

Engineering Contradiction:

Improvelong-term culture capabilityVSAvoidtissue-specific applicability

Core Design Contradiction:

ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent applies local quality by creating a breast-specific culture medium formulated with particular growth factors (EGF, FGF7, FGF10, IGF-1, HGF) and extracellular matrix components (Matrigel, laminin-521) that are specifically optimized for breast epithelial stem cells. This specialized formulation addresses the unique nutritional and signaling requirements of breast tissue while other conventional media fail to support long-term culture of these cells.

Inventive Principle:

Principle #3Local quality

2Manufacturing precision

If conventional culture methods are used, then cell culture is simple, but breast organoid formation that resembles tumours cannot be achieved

Engineering Contradiction:

Improveorganoid tumour resemblanceVSAvoidculture medium composition

Core Design Contradiction:

Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent employs composite materials by combining multiple extracellular matrix components (Matrigel, laminin-521, collagen IV) with a specific cocktail of growth factors and signaling molecules. This composite culture medium recreates the complex tumor microenvironment, enabling breast organoids to form structures that closely resemble actual breast tumors while maintaining culturable viability.

Inventive Principle:

Principle #40Composite materials

3Productivity

If existing culture systems are used, then initial cell expansion is possible, but cultures stop expanding after 2-3 passages

Engineering Contradiction:

Improvecell expansion capacityVSAvoidculture duration

Core Design Contradiction:

ProductivityVSDuration of action of stationary object

Solution Approach 1:

The patent implements continuity of useful action by formulating a culture medium that sustains breast epithelial stem cell proliferation indefinitely across multiple passages. The medium contains sustained-release growth factors and signaling molecules (EGF, FGF7, FGF10, IGF-1, HGF, Wnt3a, R-spondin1) that continuously activate proliferation pathways, preventing culture arrest and enabling long-term productive expansion.

Inventive Principle:

Principle #20Continuity of useful action

Data Source

PatentUS20250154472A1Culture Medium for Expanding Breast Epithelial Stem Cells

Publication Date: 2025.05.15 KONINK NEDERLANDSE AKADE VAN WETENSCHAPPEN

AI summary

The invention relates to improved culture methods for expanding epithelial stem cells and obtaining organoids, to culture media involved in said methods, and to uses of said organoids.